Rational design of molecular phototheranostic platform for NIR-II fluorescence imaging guided chemodynamic-photothermal combined therapy

Gui-long Wu,Bin Sun,Yuxuan He,Xiaofeng Tan,Qi Pan,Sha Yang,Na Li,Minghui Wang,Peixian Wu,Fen Liu,Hao Xiao,Li Tang,Shoujun Zhu,Qinglai Yang
DOI: https://doi.org/10.1016/j.cej.2023.142372
IF: 15.1
2023-03-17
Chemical Engineering Journal
Abstract:The strategy of synergetic chemodynamic treatment (CDT) and photothermal therapy (PTT) to improve the anticancer effect has been a hot spot in the field of biomedicine. Herein, a high-performance near-infrared II (NIR-II) fluorescence imaging-guided molecular phototheranostic platform () was designed via a convenient strategy. can serve as a PTT agent to kill cancer cells under near-infrared laser (808 nm) irradiation and a CDT agent to convert the endogenously less reactive H 2 O 2 into the harmful •OH, simultaneously deplete the glutathione (GSH) to achieve an amplified CDT as well. Notably, PTT-induced hyperthermia can further enhance the CDT effect, achieving a synergistic PTT/CDT therapy. Due to the enhanced permeability and retention (EPR) effect and the high GSH microenvironment of the tumor, exhibited much higher tumor accumulation revealed by NIR-II fluorescence imaging. More importantly, efficiently damages tumorous tissues without inducing side effects to normal tissues under 808 nm laser irradiation. This work has proposed an alternative PTT-CDT combined therapy platform based on a rational design of disintegrable NIR-II fluorescence imaging-guided molecular for effective tumor treatment.
engineering, chemical, environmental
What problem does this paper attempt to address?